Today: 21 May 2026
Browse Category

NASDAQ:IRON 17 October 2025 - 1 January 2026

Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next

Disc Medicine (NASDAQ: IRON) shares fell 11.5% to $80.04 on Dec. 20, 2025, after a STAT News report raised doubts about the effectiveness of its lead drug bitopertin and the FDA’s fast-track voucher process. The stock traded between $71.46 and $94.60 on heavy volume after Truist Securities cited the report, fueling concerns about the viability of accelerated approval.
20 December 2025
·
Disc Medicine (NASDAQ: IRON) Stock Tumbles on Insider-Selling Headlines as Bitopertin FDA Decision Nears — News, Analyst Forecasts, and What to Watch (Dec. 19, 2025)

Disc Medicine (NASDAQ: IRON) Stock Tumbles on Insider-Selling Headlines as Bitopertin FDA Decision Nears — News, Analyst Forecasts, and What to Watch (Dec. 19, 2025)

Disc Medicine (NASDAQ: IRON) shares fell about 10% to $81 in heavy trading Friday, after a series of insider sales by executives and directors appeared in SEC filings. The drop comes ahead of an expected FDA decision on bitopertin for EPP. CEO John Quisel, director Kevin Bitterman, and William Savage all disclosed recent stock sales. The stock had closed at $90.44 the prior session.
19 December 2025
·
Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine shares jumped 25.5% to $93 on October 17, 2025, after the FDA granted a Commissioner’s National Priority Voucher for its lead drug, bitopertin. The company filed a New Drug Application for bitopertin in late September; with the voucher, an approval decision could come as soon as late December. Several analysts raised their price targets sharply following the FDA news.
17 October 2025
·

Stock Market Today

  • Official Market Notice: New Debt Securities Listings
    May 21, 2026, 4:32 AM EDT. The market sees new debt and debt-like securities listings including Ecobank Transnational's Fixed Rate Reset Tier 2 Notes due 2036, Absa Group's Additional Tier 1 Notes, and European Bank for Reconstruction & Development's 4.651% Callable Green Transition Notes due 2036. Barclays Bank PLC listed securities due 2032 and Barclays PLC introduced multiple Resetting Senior Callable Notes with varying maturities between 2030 and 2037. These offerings present investors with long-dated fixed income options in USD, GBP, and JPY denominations.

Latest articles

Intel Stock Just Snapped Back — Why Wall Street Is Chasing the Chip Comeback

Intel Stock Just Snapped Back — Why Wall Street Is Chasing the Chip Comeback

21 May 2026
Intel last traded at $118.96, up 7.4%, as chip stocks rebounded ahead of U.S. market open. The move followed analyst price target hikes and renewed focus on AI-related demand for CPUs. Nvidia forecast $91 billion in second-quarter revenue and announced an $80 billion buyback, but its shares fell in after-hours trading. The next U.S. market holiday is Memorial Day, May 25.
EasyJet Share Price Alert: Fuel Shock Puts Summer Rebound Under Pressure

EasyJet Share Price Alert: Fuel Shock Puts Summer Rebound Under Pressure

21 May 2026
EasyJet shares fell 0.6% to 344.9 pence in early London trading after the airline posted a £552 million first-half loss and warned of an uncertain full-year outlook due to higher fuel costs and weaker summer bookings. The company is 72% hedged on fuel but remains exposed to spot prices, which have surged after the Iran conflict. Bookings for the second half are 58% sold, reflecting shorter lead times.
Possible SpaceX IPO May Mean Big Windfall for Musk Associate, Raises Questions for Valor

Possible SpaceX IPO May Mean Big Windfall for Musk Associate, Raises Questions for Valor

21 May 2026
Antonio Gracias, founder of Valor Equity Partners, holds about 7.3% of SpaceX’s Class A stock, valued at roughly $91.6 billion at a $1.5 trillion valuation, according to a regulatory filing. The same filing disclosed over $20 billion in AI infrastructure lease obligations tied to Valor-linked entities. SpaceX is targeting a $1.75 trillion IPO valuation, with a possible June 12 Nasdaq debut.
Go toTop